Lymphatic mapping and sentinel lymph node biopsy for breast cancer
Related Experiment Video
Updated: Aug 19, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
Douglas Reintgen1, Rosemary Giuliano, Charles Cox
1Comprehensive Breast Cancer Program, Lakeland Regional Cancer Center, FL 33804-1057, USA.
Abstract:
Lymphatic mapping and sentinel lymph node mapping have changed the standard of surgical care for patients with melanoma and have the potential to do the same for women with breast cancer. The technique will result in more accurate disease staging and in less morbidity. Preoperative lymphoscintigraphy and the intraoperative mapping technique are being standardized across the country. With the lymphatic mapping technique, approximately 10% of the so-called histologic negative population will be more accurately staged. National trials are ongoing to determine the clinical significance of the missed micrometastatic

